Synopsis
0
CEP/COS
0
JDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Global Sales Information
Market Place
ABOUT THIS PAGE
94
PharmaCompass offers a list of Choline Alfoscerate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Choline Alfoscerate manufacturer or Choline Alfoscerate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Choline Alfoscerate manufacturer or Choline Alfoscerate supplier.
A Glycerophosphorylcholine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Glycerophosphorylcholine, including repackagers and relabelers. The FDA regulates Glycerophosphorylcholine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Glycerophosphorylcholine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Glycerophosphorylcholine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Glycerophosphorylcholine supplier is an individual or a company that provides Glycerophosphorylcholine active pharmaceutical ingredient (API) or Glycerophosphorylcholine finished formulations upon request. The Glycerophosphorylcholine suppliers may include Glycerophosphorylcholine API manufacturers, exporters, distributors and traders.
click here to find a list of Glycerophosphorylcholine suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A Glycerophosphorylcholine DMF (Drug Master File) is a document detailing the whole manufacturing process of Glycerophosphorylcholine active pharmaceutical ingredient (API) in detail. Different forms of Glycerophosphorylcholine DMFs exist exist since differing nations have different regulations, such as Glycerophosphorylcholine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Glycerophosphorylcholine DMF submitted to regulatory agencies in the US is known as a USDMF. Glycerophosphorylcholine USDMF includes data on Glycerophosphorylcholine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Glycerophosphorylcholine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Glycerophosphorylcholine suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Glycerophosphorylcholine Drug Master File in Korea (Glycerophosphorylcholine KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Glycerophosphorylcholine. The MFDS reviews the Glycerophosphorylcholine KDMF as part of the drug registration process and uses the information provided in the Glycerophosphorylcholine KDMF to evaluate the safety and efficacy of the drug.
After submitting a Glycerophosphorylcholine KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Glycerophosphorylcholine API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Glycerophosphorylcholine suppliers with KDMF on PharmaCompass.
A Glycerophosphorylcholine written confirmation (Glycerophosphorylcholine WC) is an official document issued by a regulatory agency to a Glycerophosphorylcholine manufacturer, verifying that the manufacturing facility of a Glycerophosphorylcholine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Glycerophosphorylcholine APIs or Glycerophosphorylcholine finished pharmaceutical products to another nation, regulatory agencies frequently require a Glycerophosphorylcholine WC (written confirmation) as part of the regulatory process.
click here to find a list of Glycerophosphorylcholine suppliers with Written Confirmation (WC) on PharmaCompass.
Glycerophosphorylcholine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Glycerophosphorylcholine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Glycerophosphorylcholine GMP manufacturer or Glycerophosphorylcholine GMP API supplier for your needs.
A Glycerophosphorylcholine CoA (Certificate of Analysis) is a formal document that attests to Glycerophosphorylcholine's compliance with Glycerophosphorylcholine specifications and serves as a tool for batch-level quality control.
Glycerophosphorylcholine CoA mostly includes findings from lab analyses of a specific batch. For each Glycerophosphorylcholine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Glycerophosphorylcholine may be tested according to a variety of international standards, such as European Pharmacopoeia (Glycerophosphorylcholine EP), Glycerophosphorylcholine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Glycerophosphorylcholine USP).
